Yuanyuan
Chen
a,
Hui
Zhong
a,
Jianbo
Wang
b,
Xiuyan
Wan
a,
Yanhua
Li
a,
Wei
Pan
a,
Na
Li
*a and
Bo
Tang
*a
aCollege of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Institute of Molecular and Nano Science, Shandong Normal University, Jinan 250014, P. R. China. E-mail: lina@sdnu.edu.cn; tangb@sdnu.edu.cn
bRadiation Department, Qilu Hospital of Shandong University, Jinan 250100, P. R. China
First published on 4th June 2020
Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.
![]() | ||
Fig. 1 (a) Generation of ROS measured by CLSM after different treatments of B16-F10 cells under hypoxic conditions after labeling with DCFH-DA (a). |
The authors also regret that inadvertent errors were included in Fig. S12a, S22a and S26 in the original version of the ESI. The corrected images are now presented in the updated version of the ESI. These corrections do not influence any of the experimental results, discussion or conclusions reported in the article.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2020 |